Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on March 2, 2026

Mar. 2, 2026

Psychotherapy Works: A Private Practice To Help Individuals in Little Rock, AR

Indeterminate EIN Presswire

Mar. 2, 2026

MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Mar. 2, 2026

Alignment Healthcare Announces Secondary Offering

Indeterminate GlobeNewswire

Mar. 2, 2026

BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase

Indeterminate GlobeNewswire

Mar. 2, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 2, 2026

Multi-Omic Fluidic Samplers Market Forecast 2026–2036: Market to Reach USD 2,757 Million by 2036 at 8.7% CAGR

Indeterminate EIN Presswire

Mar. 2, 2026

Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026

Indeterminate GlobeNewswire

Mar. 2, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 2, 2026

Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

Indeterminate GlobeNewswire

Mar. 2, 2026

Immuneering to Present at the Leerink Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 2, 2026

Myriad Commercially Launches Precise MRD with Select Community Oncologists

Indeterminate GlobeNewswire

Mar. 2, 2026

Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

Indeterminate GlobeNewswire

Mar. 2, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 2, 2026

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program

Indeterminate GlobeNewswire

Mar. 2, 2026

Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Mar. 2, 2026

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Mar. 2, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 2, 2026

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 2, 2026

Award Winning Plastic Surgeon Opens New Facility in Greater Philadelphia Area

Indeterminate EIN Presswire